Royce & Associates LP 4 D Molecular Therapeutics, Inc. Transaction History

Royce & Associates LP

  • $10.8 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$9.76 - $21.25 $183,185 - $398,841
18,769 New
18,769 $380,000
Q1 2022

May 05, 2022
SELL
$13.16 - $22.64 $122,388 - $210,552
-9,300 Closed
0 $0
Q4 2021

Feb 07, 2022
BUY
$19.56 - $32.94 $181,908 - $306,342
9,300 New
9,300 $204,000

Others Institutions Holding FDMT

# of Institutions
157
Shares Held
50.3M
Call Options Held
718K
Put Options Held
370K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $675M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email